Randall C. Schatzman, President and CEO at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 30,000 shares at $25.03 ($751K) on 2017-02-09, disclosed to the SEC on 2017-02-13.
Open-market sale of $751k ALDR by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2016-10-05 | $424K | — | Filing → |
| ALDR | SELL | 2016-09-06 | $650K | — | Filing → |
| ALDR | SELL | 2016-08-03 | $622K | — | Filing → |